logo
Select company
Select metric
-2350.43%EBIT Margin
VS
Market
4
Sector
14
Industry
25
History
-
$ 1.86Close
$ 0.55 - $ 2.38 52-Week Range
Ticker Information

Ticker

CNTB

Company Name

CONNECT BIOPHARMA HOLDINGS LTD

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CONNECT BIOPHARMA HOLDINGS LTD - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CNTB - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -46.19M-2350.43%$ 1.97M
12/31/2024$ -15.4M-59.17%$ 26.03M
6/30/2024$ -22.67M-94.02%$ 24.12M
12/31/2023$ -59.36M0%$ 0
6/30/2023$ -83M0%$ 0
12/31/2022$ -108.9M0%$ 0
6/30/2022$ -104.55M0%$ 0
12/31/2021$ -178.8M0%$ 0
12/31/2020$ -106.36M0%$ 0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CONNECT BIOPHARMA HOLDINGS LTD's latest trailing twelve months (TTM) EBIT % stands at 0%.
  • Over the past 5 years, CONNECT BIOPHARMA HOLDINGS LTD's average EBIT % has been -834.54%.
  • The median EBIT % for CONNECT BIOPHARMA HOLDINGS LTD during this period was -94.02%
  • CONNECT BIOPHARMA HOLDINGS LTD reached its highest EBIT % over the past 5 years at -59.17%.
  • The lowest EBIT % recorded by CONNECT BIOPHARMA HOLDINGS LTD in the same timeframe -2350.43%

CONNECT BIOPHARMA HOLDINGS LTD's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
ORMP : ORAMED PHARMACEUTICALS INC -1750.95%OTLK : OUTLOOK THERAPEUTICS INC -2881.12%OBIO : ORCHESTRA BIOMED HOLDINGS INC -2366.27%NTRB : NUTRIBAND INC -397.54%BTAI : BIOXCEL THERAPEUTICS INC -4022.24%AVR : ANTERIS TECHNOLOGIES GLOBAL CORP -3382.86%PYXS : PYXIS ONCOLOGY INC -3481.1%AVTX : AVALO THERAPEUTICS INC -10946.03%DTIL : PRECISION BIOSCIENCES INC -6097.94%LGVN : LONGEVERON INC -894.31%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for CONNECT BIOPHARMA HOLDINGS LTD is calculated as follows: EBIT [ $ -106.36M ] / Revenues [ $ 0 ]
(=) EBIT % [ 0% ]

CNTB - EBIT Margin, Last 5 years

-2350.43%

Minimum

Jun 30, 2025

-59.17%

Maximum

Dec 31, 2024

-834.54%

Average

-94.02%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%